KG Pharma ApS: Financial statements 2025
CVR: 44911469
Source: annual report 2025, Danish Business Authority
18/06/2024 – 30/06/2025
KG Pharma ApS (CVR 44911469) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -23,420 and a net result of DKK -18,259. Equity in the 2025 report amounted to DKK 21,741. The solvency ratio was 59.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -23,420
- Profit/Loss
- DKK -18,259
- Equity
- DKK 21,741
- Total Assets
- DKK 36,741
- Employees
- 1
Official annual report
How creditworthy is KG Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout KG Pharma ApS
KG Pharma ApS is a Danish company of the type Anpartsselskab based in Havdrup, founded in 2024. The company is registered under the industry Installation af isolering. The management consists of Nicolai Rømer Wiksten. The company is owned by KlimaGruppen ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -23,420 and a net result of DKK -18,259. Equity in the 2025 report amounted to DKK 21,741.